Phase II Trial of Magrolimab and Cetuximab With Pembrolizumab or Docetaxel for Recurrent/Metastatic Head Neck Squamous Cell Carcinoma
Phase 2 Terminated
4 enrolled 11 charts
A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With HNSCC (Master Protocol) (Pegathor Head and Neck 204)
Phase 2 Terminated
59 enrolled 18 charts
XXL_2022-01
Phase 3 Terminated
19 enrolled
FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors
Phase 1 Terminated
5 enrolled
Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With HPV Positive, KRAS-Variant Stage III-IV Oropharyngeal Squamous Cell Carcinoma
Phase 2 Terminated
1 enrolled
A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma
Phase 2 Terminated
30 enrolled 17 charts
Super-Selective Intraarterial Infusion of Cetuximab (Erbitux) With or Without Radiation Therapy for the Treatment of Unresectable Recurrent Squamous Cell Carcinoma of the Head and Neck
Phase 1 Terminated
11 enrolled
Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck Cancer
Phase 1 Terminated
4 enrolled
Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer
Phase NA Terminated
8 enrolled 9 charts
COPAN-ORL06
Phase 1/2 Terminated
11 enrolled
Study of Radiation (RT) Concurrent With Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (SCC)
Phase 2 Terminated
23 enrolled 18 charts
EXTAX
Phase 2 Terminated
17 enrolled 8 charts
A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Phase 1/2 Terminated
179 enrolled 38 charts
Induction Chemo Then Concurrent Chemoradiotherapy With Cetuximab in Locally Advanced Head and Neck Squamous Cell Cancer
Phase 2 Terminated
7 enrolled 5 charts
Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and Neck
Phase 4 Terminated
4 enrolled
Study in Locally Advanced Squamous Cell Carcinoma of Head and Neck
Phase 2 Terminated
50 enrolled 9 charts
AGMT_HNO_PN
Phase 3 Terminated
8 enrolled
A Phase Ib Study of Neoadjuvant of Cetuximab Plus Motolimod and Cetuximab Plus Motolimod Plus Nivolumab
Phase 1 Terminated
18 enrolled
Induction and Concurrent Chemoradiotherapy With Cetuximab for Patients With Locally Advanced Nasopharyngeal Carcinoma
Phase 2 Terminated
3 enrolled
A Phase I Study of Nilontinib and Cetuximab in Patients With Solid Tumors
Phase 1 Terminated
15 enrolled
Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Positive mCRC and HNSCC Patients After Progression on Cetuximab or Panitumumab Therapy
Phase 1 Terminated
13 enrolled
Dasatinib
Phase 1 Terminated
22 enrolled 8 charts
Patritumab With Cetuximab and a Platinum Agent for Squamous Cell Carcinoma (Cancer) of the Head and Neck (SCCHN )
Phase 2 Terminated
87 enrolled 13 charts
RAD001 in Combination With Cetuximab and Cisplatin in Recurrent and Metastatic SCCHN
Phase 1/2 Terminated
9 enrolled 9 charts
Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery
Phase 2 Terminated
47 enrolled
CTXMAB+RT
Phase 2 Terminated
70 enrolled
Study of Albumin Bound-Paclitaxel for Treatment of Recurrent or Metastatic Head and Neck Cancer With Cetuximab
Phase 2 Terminated
10 enrolled 8 charts
Cetuximab and Dasatinib in Recurrent Squamous Cell Carcinoma
Phase 2 Terminated
21 enrolled 8 charts
Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study
Phase 2 Terminated
7 enrolled 6 charts
Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck
Phase 1/2 Terminated
29 enrolled 13 charts
Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer
Phase 2 Terminated
16 enrolled 5 charts
Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinoma
Phase 2 Terminated
5 enrolled 9 charts
Boron Neutron Capture Therapy (BNCT) Combined With Cetuximab in the Treatment of Locally Recurred Head and Neck Cancer
Phase 1/2 Terminated
17 enrolled
Radiation Therapy and Cetuximab in Treating Patients With Recurrent Head and Neck Cancer
Phase NA Terminated
2 enrolled 6 charts
Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE)
Phase 2 Terminated
4 enrolled 5 charts
Use of Pharmacogenetics to Select Erbitux or Cisplatin to Treat Head and Neck Cancer
Phase NA Terminated
2 enrolled 7 charts
EMD 1201081 + 5-FU + Cisplatin + Cetuximab in Subjects With Recurrent / Metastatic Squamous Cell Carcinoma of the Head and Neck
Phase 1 Terminated
13 enrolled
Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx
Phase 3 Terminated
32 enrolled
Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck
Phase 1 Terminated
36 enrolled
Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors
Phase 1/2 Terminated
54 enrolled
Combination of Cisplatin, Cetuximab and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Phase 1/2 Terminated
11 enrolled